Tarsons Products Limited has informed the Exchange regarding Outcome of Board Meeting held on August 12, 2025.
TARSONS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tarsons Products' board approved its Q1 FY26 (quarter ended June 30, 2025) unaudited financial results, both standalone and consolidated. Consolidated revenue from operations rose modestly to Rs. 913.64 million from Rs. 847.97 million in Q1 FY25 (~7.7% YoY growth), but was sharply lower sequentially versus Rs. 1,126.91 million in Q4 FY25. Standalone revenue grew to Rs. 712.79 million from Rs. 648.49 million YoY. However, profitability weakened materially — consolidated PAT fell to Rs. 17.83 million from Rs. 40.16 million YoY (~56% drop), and standalone PAT declined to Rs. 35.70 million from Rs. 64.61 million. PBT margins compressed notably on both bases. The board also fixed September 22, 2025 as the date for the 42nd AGM, with September 12, 2025 as the e-voting cut-off date. Auditor Price Waterhouse Chartered Accountants LLP issued an unmodified limited review conclusion.
Despite modest top-line growth, sharply lower profits and margin compression in Q1 FY26 are likely to weigh negatively on the stock. Investors should also note the disclosure that excess remuneration was paid to the Managing Director and Whole Time Director, for which shareholder waiver approval will be sought at the upcoming AGM.